IXHL
INCANNEX HEAL (IXHL)
NASDAQ
$3.07+$0.008 (+0.26%)
Price as of Jun 03, 2026 7:52 PM EDT
  • $40.1M
    Market Cap
  • -46.52%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
86,000
+616.67%
12,000
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
6,338
N/A
Gross Profit
86,000
+616.67%
12,000
N/A
0
+100.00%
-6,338
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
1.9M
-32.55%
2.7M
N/A
Research and Development Expense
-10.7M
-16.55%
-12.9M
+37.53%
-9.4M
+74.33%
-5.4M
N/A
Depreciation and Amortization Expense
246,000
+138.83%
103,000
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
23.9M
-20.56%
30.1M
N/A
N/A
N/A
N/A
N/A
Operating Profit
-23.8M
-20.81%
-30.0M
N/A
N/A
N/A
N/A
N/A
Interest Income
62,000
-69.90%
206,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
62,000
-69.90%
206,000
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-23.1M
-298.90%
11.6M
+743.50%
1.4M
+1,784.03%
73,069
N/A
Income before Taxes
-46.9M
+154.41%
-18.4M
-7.76%
-20.0M
+34.06%
-14.9M
N/A
Income Taxes
N/A
N/A
30,000
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-46.9M
+154.00%
-18.5M
-7.61%
-20.0M
+34.06%
-14.9M
N/A
Net Income from Continuing Operations Applicable to Common
-46.9M
+154.41%
-18.4M
-7.76%
-20.0M
+34.06%
-14.9M
N/A
Basic EPS and Net Income
-1.35
+17.39%
-1.15
-11.54%
-1.30
+4.00%
-1.25
N/A
Diluted EPS and Net Income
-1.35
+17.39%
-1.15
-11.54%
-1.30
+4.00%
-1.25
N/A
Basic Weighted Average Shares
34.5M
+113.15%
16.2M
-98.95%
1.5B
+109,673.36%
1.4M
N/A
Diluted Weighted Average Shares
34.5M
+113.15%
16.2M
-98.95%
1.5B
+109,673.36%
1.4M
N/A
Balance Sheet
Cash and Cash Equivalents
15.0M
+156.73%
5.9M
-82.44%
33.4M
-11.03%
37.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
15.0M
+156.73%
5.9M
-82.44%
33.4M
-11.03%
37.5M
N/A
Total Current Assets
20.0M
+23.21%
16.2M
-53.29%
34.7M
-8.43%
37.9M
N/A
Accumulated Depreciation
269,000
+113.49%
126,000
N/A
N/A
N/A
-32,221
N/A
Property and Plant and Equipment and Net
227,000
-51.91%
472,000
+6.39%
443,652
N/A
N/A
N/A
Total Long-Term Assets
227,000
-51.91%
472,000
-99.12%
53.9M
+64,102.97%
83,960
N/A
Total Assets
20.4M
+19.94%
17.0M
-80.76%
88.6M
+133.87%
37.9M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
7.0M
+24.27%
5.6M
+46.14%
3.8M
+91.28%
2.0M
N/A
Total Long-Term Debt
100,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
74,000
-64.76%
210,000
-65.91%
616,087
N/A
N/A
N/A
Total Liabilities
7.1M
+21.06%
5.8M
+30.66%
4.5M
+121.92%
2.0M
N/A
Retained Earnings
-157.6M
+42.36%
-110.7M
+40.49%
-78.8M
+33.98%
-58.8M
N/A
Total Stockholders Equity
13.4M
+19.36%
11.2M
-86.67%
84.1M
+134.54%
35.9M
N/A
Total Shares Outstanding
194.4M
+1,124.59%
15.9M
N/A
N/A
N/A
3.0M
N/A
Cash Flow
Cash from Operating Activities
-12.5M
-21.03%
-15.8M
-0.61%
-15.9M
+24.48%
-12.8M
N/A
Capital Expenditures
8,000
-97.11%
277,000
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-8,000
-97.11%
-277,000
-41.91%
-476,873
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
21.4M
N/A
N/A
N/A
12.3M
-70.19%
41.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-27,661.63%
-88.95%
-250,341.67%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-250.09%
+615.62%
-34.95%
+10.61%
-31.60%
N/A
N/A
N/A
Return on Equity
-381.09%
+884.21%
-38.72%
+16.28%
-33.30%
N/A
N/A
N/A
Revenue Growth
616.67%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.86
-0.86%
2.88
-68.04%
9.02
N/A
N/A
N/A
Cash Ratio
2.15
+106.60%
1.04
-87.99%
8.68
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow